[Low-dosage ASA should not be given as primary prevention. The risk is greater than the benefit--also in high risk of cardiovascular disease].

Autor: Håkansson J; Krokoms hälsocentral. jan.hakansson@jll.se, Hernborg A
Jazyk: švédština
Zdroj: Lakartidningen [Lakartidningen] 2010 Feb 3-9; Vol. 107 (5), pp. 260-2.
Databáze: MEDLINE